Filters close
Released: 18-Mar-2024 5:05 PM EDT
UC Irvine-led research team discovers role of key enzymes that drive cancer mutations
University of California, Irvine

A research team led by the University of California, Irvine has discovered the key role that the APOBEC3A and APOBEC3B enzymes play in driving cancer mutations by modifying the DNA in tumor genomes, offering potential new targets for intervention strategies.

Newswise: Hackensack Meridian Jersey Shore University Medical Center Welcomes Dr. Lee Peng as Chief of Gastroenterology
Released: 18-Mar-2024 5:05 PM EDT
Hackensack Meridian Jersey Shore University Medical Center Welcomes Dr. Lee Peng as Chief of Gastroenterology
Hackensack Meridian Health

Hackensack Meridian Jersey Shore University Medical Center welcomed Lee F. Peng, M.D., PhD, as section chief of gastroenterology, department of medicine.

Newswise: Role in mitochondrial metabolism paints more complete picture of MCL-1 function
Released: 18-Mar-2024 3:05 PM EDT
Role in mitochondrial metabolism paints more complete picture of MCL-1 function
St. Jude Children's Research Hospital

Scientists at St. Jude Children’s Research Hospital have uncovered a metabolic role for cell-survival protein MCL-1, potentially explaining previous clinical trial setbacks.

Released: 18-Mar-2024 3:05 PM EDT
Memorial Sloan Kettering Awarded Prestigious NCI Grant to Further Advance CAR T Cell Treatments for Solid Tumors
Memorial Sloan Kettering Cancer Center

A team at Memorial Sloan Kettering Cancer Center (MSK) led by thoracic surgeon Prasad Adusumilli, MD, has been awarded a distinguished UG3/UH3 grant from the National Cancer Institute (NCI) to advance research and testing of chimeric antigen receptor (CAR) T cell therapy for solid tumors.

Released: 18-Mar-2024 10:05 AM EDT
Attacking metastatic prostate cancer early with combination treatment approach improves outcomes in preliminary study
University of California, Los Angeles (UCLA), Health Sciences

A team of UCLA Health Jonsson Comprehensive Cancer Center investigators has shown the combination of a short course of powerful and intense hormonal therapy with targeted radiation is safe and effective in treating people with prostate cancer that has come back and has spread to other parts of the body.

Released: 18-Mar-2024 9:00 AM EDT
St. Baldrick’s Foundation Awards $50,000 Grant to Expand Pediatric Cancer Clinical Trials at K. Hovnanian Children’s Hospital
Hackensack Meridian Health

St. Baldrick’s Foundation Awards $50,000 Grant to Expand Pediatric Cancer Clinical Trials at K. Hovnanian Children’s Hospital

Newswise: Yale Cancer Center experts present new research on obesity, tobacco, evolution, and early onset cancers at leading oncology conference
Released: 18-Mar-2024 7:00 AM EDT
Yale Cancer Center experts present new research on obesity, tobacco, evolution, and early onset cancers at leading oncology conference
Yale Cancer Center/Smilow Cancer Hospital

Yale Cancer Center (YCC) and Smilow Cancer Hospital physicians and scientists will share new data for breakthrough and emerging cancer treatments as well as new discoveries in obesity, tobacco, evolution, and early onset cancers in early April at the American Association for Cancer Research (AACR) annual meeting.

Newswise:Video Embedded artificial-mucus-identifies-link-to-tumor-formation
VIDEO
11-Mar-2024 11:45 PM EDT
Artificial mucus identifies link to tumor formation
American Chemical Society (ACS)

Mucus is critical to human health. To explore how, researchers synthesized its major component, sugar-coated proteins called mucins, and discovered that changing the mucins of healthy cells to be more cancer-like made cells act more cancer-like. They will present their results at ACS Spring 2024.

   
Newswise: Some lymphomas become resistant to treatment. Gene discovery may offer path to overcome it.
Released: 15-Mar-2024 3:05 PM EDT
Some lymphomas become resistant to treatment. Gene discovery may offer path to overcome it.
University of Wisconsin–Madison

Patients with some types of lymphoma that become resistant to standard treatments may benefit from a therapy that University of Wisconsin–Madison researchers are evaluating after they discovered a key process that fuels the blood cancers’ resistance to current drugs.

Newswise: We Now Know Why Killer T Cells Lose Energy Inside of Solid Tumors
Released: 15-Mar-2024 11:05 AM EDT
We Now Know Why Killer T Cells Lose Energy Inside of Solid Tumors
University of North Carolina School of Medicine

Researchers at the UNC School of Medicine have found that a metabolic enzyme called Acetyl-CoA Carboxylase causes T cells to store fat when they are in solid tumors, rather than burning fat for energy.

Released: 15-Mar-2024 11:00 AM EDT
New Research in March: Colorectal Cancer, Kidney Health, OR Supply Costs, and More
American College of Surgeons (ACS)

The March issue of the Journal of the American College of Surgeons (JACS) features new research on topics ranging from colorectal cancer and social vulnerability to operating room supply costs, the rise in school shootings since 1970, and the impact of permitless open carry laws on suicide rates, among others.

   
Released: 14-Mar-2024 2:30 PM EDT
Scott Armstrong named Senior Vice President for Drug Discovery and Chief Research Strategy Officer at Dana-Farber
Dana-Farber Cancer Institute

Scott Armstrong, MD, PhD, has been named senior vice president for drug discovery and chief research strategy officer at Dana-Farber Cancer Institute. In this new role, he will lead Dana-Farber's institutional research strategy with an initial focus on therapeutic discovery work.

Released: 14-Mar-2024 2:05 PM EDT
A soja aumenta o risco de câncer de mama?
Mayo Clinic

A pergunta está gerando muitos debates. Há alguma conexão entre a soja e o câncer de mama? A soja contém isoflavonas, que são estrogênios vegetais. Os níveis elevados de estrogênio estão vinculados com os riscos de câncer de mama. Entretanto, há estudos que demonstram que os produtos de soja não contêm níveis suficientemente elevados de estrogênio para aumentar as chances de desenvolvimento de câncer de mama.

Newswise: New Study Examines if ‘Inoperable’ Pancreatic Tumors Can Be Safely Removed
Released: 14-Mar-2024 12:00 PM EDT
New Study Examines if ‘Inoperable’ Pancreatic Tumors Can Be Safely Removed
Keck Medicine of USC

A clinical trial from Keck Medicine of USC aims to provide a surgical solution for patients with a form of advanced pancreatic cancer previously considered inoperable.

Newswise: 1920_ai-machine-learning-cedars-sinai.jpg?10000
Released: 14-Mar-2024 10:05 AM EDT
National AI Campus Helps Advance Medical, Scientific Innovation
Cedars-Sinai

One group is using machine learning to develop a more reliable and efficient screening method for bladder cancer.

Newswise: 38 Year Old Colon Cancer Survivor Re-Writes Her Outlook On Life
Released: 14-Mar-2024 10:05 AM EDT
38 Year Old Colon Cancer Survivor Re-Writes Her Outlook On Life
Hackensack Meridian Health

34 year old goes to the emergency department at the urging of her brother for pain from what she thought was appendicitis and gets shock of a lifetime.

Newswise: The Medical Minute: Colon cancer rates higher in rural areas
Released: 14-Mar-2024 10:05 AM EDT
The Medical Minute: Colon cancer rates higher in rural areas
Penn State Health

Technology to stop or prevent colon cancer keeps improving. Still, incident rates remain more stubborn in rural areas than urban centers. The dean of Penn State College of Medicine talks about the barriers.


Showing results

120 of 24508

close
4.34251